These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry. Reidy KJ; Hjorten R; Parekh RS Curr Opin Pediatr; 2018 Apr; 30(2):252-259. PubMed ID: 29406442 [TBL] [Abstract][Full Text] [Related]
6. Association of Paranjpe I; Chaudhary K; Paranjpe M; O'Hagan R; Manna S; Jaladanki S; Kapoor A; Horowitz C; DeFelice N; Cooper R; Glicksberg B; Bottinger EP; Just AC; Nadkarni GN Clin J Am Soc Nephrol; 2020 Mar; 15(3):401-403. PubMed ID: 32079610 [No Abstract] [Full Text] [Related]
7. Nephropathy Progression in African Americans With a Family History of ESKD: Implications for Clinical Trials in APOL1-Associated Nephropathy. Freedman BI; Spainhour M; Hicks PJ; Turner J; Robertson J; Langefeld CD; Murea M; Divers J Am J Kidney Dis; 2019 Aug; 74(2):284-286. PubMed ID: 31076172 [No Abstract] [Full Text] [Related]
13. Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions. Young BA; Blacksher E; Cavanaugh KL; Freedman BI; Fullerton SM; Kopp JB; Umeukeje EM; West KM; Wilson JG; Burke W; Am J Nephrol; 2019; 50(4):303-311. PubMed ID: 31480040 [TBL] [Abstract][Full Text] [Related]
14. APOL1 risk variants and kidney disease: what we know so far. Siemens TA; Riella MC; Moraes TP; Riella CV J Bras Nefrol; 2018; 40(4):388-402. PubMed ID: 30052698 [TBL] [Abstract][Full Text] [Related]
15. APOL1 and kidney disease: new insights leading to novel therapies. Freedman BI Am J Kidney Dis; 2015 Jul; 66(1):9-11. PubMed ID: 26111904 [No Abstract] [Full Text] [Related]
16. Joint Associations of Maternal-Fetal APOL1 Genotypes and Maternal Country of Origin With Preeclampsia Risk. Hong X; Rosenberg AZ; Zhang B; Binns-Roemer E; David V; Lv Y; Hjorten RC; Reidy KJ; Chen TK; Wang G; Ji Y; Simpson CL; Davis RL; Kopp JB; Wang X; Winkler CA Am J Kidney Dis; 2021 Jun; 77(6):879-888.e1. PubMed ID: 33359152 [TBL] [Abstract][Full Text] [Related]
17. Survival Advantage of African American Dialysis Patients with End-Stage Renal Disease Causes Related to APOL1. Lertdumrongluk P; Streja E; Rhee CM; Moradi H; Chang Y; Reddy U; Tantisattamo E; Kalantar-Zadeh K; Kopp JB Cardiorenal Med; 2019; 9(4):212-221. PubMed ID: 30995638 [TBL] [Abstract][Full Text] [Related]
18. APOL1 Genotyping in Potential African American Living Kidney Donors: Utility and Cost-Effectiveness. Gudsoorkar P; Anand M; Abu Jawdeh BG Am J Nephrol; 2020; 51(2):116-118. PubMed ID: 31940609 [TBL] [Abstract][Full Text] [Related]